Synexus acquires Research Across America
To expand its global capability and enter the US market
Synexus, a US firm focused on recruiting for and managing clinical trials for pharma, biotech and CRO customers, has acquired Research Across America for an undisclosed sum.
RAA was founded by Jeffrey Adelglass and has proven clinical trial expertise, having conducted more than 2,000 clinical trials at its dedicated research sites, the firm says.
Since being taken private in 2007 Synexus has enjoyed consistent growth. The firm already owns 25 dedicated research sites across ten countries. The addition of multiple new sites in the US means that Synexus can now offer customers access to more than 79 million potential patients.
The firm says the deal provides important capacity, US market expertise and therapeutic experience.
Christophe Berthoux, CEO of Synexus, said: 'Synexus already has a strong international footprint. This latest acquisition is an important one as it marks our entry into the US market, giving us truly global capability. We spent a great deal of time considering an appropriate partner and selected Research Across America as it has a number of synergies with the Synexus model. In addition by adding these sites to our network we have also gained expertise in areas, such as dermatology and generics, enabling us to further support our client base.'
